Creative Medical Technology Holdings Inc
Veridion Score
Composite trend over time
Why is CELZ moving today?
Creative Medical Technology Holdings Inc is a commercial-stage biotechnology company focused on the advancement of regenerative therapies in the fields of immunotherapy, endocrinology, urology, neurology, and orthopedics. Its pipeline consists of AlloStem (CELZ-201-DDT); ImmCelz (CELZ-100), a personalized supercharged immune therapy platform; CELZ-201 CREATE-1, an intervention for the treatment of recent onset Type 1 Diabetes; AlloStemSpine for treatment of lower back pain; the Alova program to treat infertility as a result of premature ovarian failure; and other regenerative treatment programs and technologies like OvaStem, CaverStem, FemCelz, StemSpine, and others for the treatment of various indications related to sexual health, spine disc disease, kidney failure, liver failure, etc.
Real vendor fields plus Veridion-computed history. Missing fields stay blank.
Warehouse intelligence for CELZ.
CELZ insider activity
Creative Medical Technology Holdings Inc
No multi-insider buying cluster in the last 90 days
Mixed: $0 across loaded Form 4 rows.
Loaded official disclosures do not show all three sources aligned on this ticker.
The current Form 4 feed did not return value-bearing open-market rows for CELZ.
CELZ contract awards, year to date.
Public federal awards linked to this ticker.
CELZ lobbying filings, year to date.
Registered lobbying filings matched to Creative Medical Technology Holdings Inc.